Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: TO ALL READERS .. If you invested in PTSC before 2005,

S&L held all the cards regarding the convertible stock, to suggest that any BoD could have progressed without their consent and with a more favorable result to PTSC is spurious


But the dividends were absolutely the BOD's choice and for that mammoth error (favoring S & L above the shareholders and threatening the company's viablity) they must be judged.

Share
New Message
Please login to post a reply